HOW CAN WE HELP?
STRATEGIC COMMUNICATIONS AND EXTERNAL ENGAGEMENT
The Einstein team includes highly-trained writers and communications experts with decades of experience, translating complex issues for key constituencies and stakeholders, using multiple formats. We provide expertise in explanatory writing and editing, social media strategic planning and implementation, newsletters and brochures, speech writing, testimony preparation and presentation development.
BRANDING AND ADVOCACY
Einstein Speaks recognizes that branding and positioning are key elements of business development. To complement our fundraising and management expertise, the Einstein team has strong speaking, representational, writing and communication skills, including the ability to translate complex global health and development issues for key constituencies using multiple formats. For example, in mid-2016, on behalf of MSI-US, Pam published an article in the New York Times' Women in the World, “Preventing teen pregnancy can be a matter of life and death,” on the dangers of teen pregnancy worldwide, with the goal of helping MSI, a London-based organization, begin to strengthen its brand in the US.
In late 2017, she published, "Meet the intrepid doctors and scientists who are viewed as the 'Zena warrior princesses of women's health,'" in the New York Times' Women in the World, to promote a new innovation for women's health that combines disease prevention with contraception.
While at IPM, Pam conceived and implemented advocacy campaigns such as “Giving Women Power Over AIDS” to help build a broad constituency for women and AIDS and enhance fundraising efforts for product development.
Given today’s realities, our team has prioritized developing and implementing social media strategies linked to stakeholder engagement and fundraising efforts.
Pam and her team have significant experience in developing and implementing risk communication strategies. For example, Pam helped to develop a strategy to navigate nonprofits through the challenging communications and advocacy landscape during studies of “early generation” products that did not prove effective against HIV, helping to ensure key stakeholders and investors remained engaged and supportive as the field moved into “next generation” products. This effort involved a sustained “rebranding” of women-centered HIV prevention products, including the development of a broad evidence-based communications and marketing strategy.